Downloaded on September 6, 2021 from Www

Total Page:16

File Type:pdf, Size:1020Kb

Downloaded on September 6, 2021 from Www PODIUM PRESENTATIONS Objective Recent studies have suggested that the subchondral bone P1 metabolism is intimately involved in cartilage degradation in osteoarthritis Autoantibodies to Heat Shock Protein 60 (hsp60) Promote Thrombus (OA). Bone remodelling is tightly regulated by a molecular triad: Formation in a Murine Model of Arterial Thrombosis OPG/RANK/RANKL. RANKL enhances osteoclastogenesis via interaction Melanie Dieude (Division of Rheumatology, The Research Institute of the with its receptor RANK, whereas OPG inhibits this osteoclastogenesis by act- McGill University Health Centre), Marc-Antoine Gillis (The Montreal Heart ing as a soluble RANKL receptor competitor. Depending on the low or high Institute, University of Montreal, Montreal), Jean-Francois Theoret (The level of PGE2, human OA subchondral osteoblasts can be discriminated into Montreal Heart Institute, University of Montreal, Montreal), Jerrold S. Levine two subpopulations: low (L) or high (H), respectively. (Section of Nephrology, University of Illinois at Chicago, Chicago, USA), Methods We investigated the modulation of OPG and RANKL levels and Eric Thorin (The Montreal Heart Institute, University of Montreal, Montreal), RANKL1 and 3 isoforms by real-time PCR, and osteoclast formation using Yahye Merhi (The Montreal Heart Institute, University of Montreal, the pre-osteoclastic cell line RAW 264.7, comparing the effects of normal to Montreal), Joyce Rauch (Division of Rheumatology, The Research Institute each OA osteoblast subpopulation (L or H). Human knee subchondral bone of the McGill University Health Centre) was also examined histologically. Further, we determined by flow cytometry Anti-heat shock protein 60 (anti-hsp60) autoantibodies from systemic lupus on L and H OA osteoblasts the level and modulation of membranous RANKL erythematosus patients induce endothelial cell apoptosis in vitro, and are upon treatment with/without osteotropic factors. associated with an increased frequency of thrombosis in patients with lupus Results Histological analysis revealed that the L OA osteoblasts had reduced anticoagulant antibodies (Dieudé et al. Arthritis Rheum 2004). However, the subchondral bone mass compared to normal, in contrast to the H OA which mechanisms responsible for anti-hsp60 autoantibody induction and pathogen- showed an increase. The OPG/RANKL mRNA ratio was significantly esis remain unclear. decreased in L OA compared to normal or H OA, and markedly increased in Objective We aimed to study how autoantibodies to murine hsp60 could be H OA compared to normal. This was further supported by the membranous induced in nonautoimmune mice, and to determine if these autoantibodies RANKL levels which were significantly elevated in L OA compared to the H would promote thrombus formation in an in vivo model of carotid artery OA and normal cells. Moreover, L OA but not H OA cells induced a signifi- thrombosis. cantly higher level of osteoclast differentiation and formation. Experiments Methods BALC/c mice were immunized with bacterial hsp65 and Freund’s with osteotropic factors revealed that i) in L OA osteoblasts, TNF-alpha, IL- adjuvant, or adjuvant alone, to produce IgG antibodies reactive with murine 1beta, PGE2, IL-6 and Vitamin D3 significantly increased the membranous hsp60 or control antibodies respectively. Naïve BALB/c mice were treated RANKL level, whereas ii) in H OA none of the factors tested affected with either purified polyclonal anti-murine hsp60 IgG antibodies or control RANKL. Finally, RANKL isoforms 1 and 3 were significantly higher in the IgG 48 hours prior to inducing carotid artery injury with FeCl3. On the day L OA compared to H OA. of the experiment, mice were anesthetized and the right carotid artery was Conclusion The OPG/RANKL ratio in the two human OA subchondral bone exposed. Blood flow through the carotid artery was measured using a minia- osteoblast subpopulations indicates different stages of this diseased tissue, in ture ultrasound flow probe interfaced with a flow meter and a computer-based which the L OA osteoblasts favour bone resorption. A better understanding of data acquisition program. The blood flow was monitored pre-FeCl3-induced the modulation of subchondral bone RANKL during the OA process will be injury to establish normal flow, and post-injury to follow thrombus formation. useful in the development of a specific therapeutic target. Blood flow decreased when thrombus formation occurred and stopped when the thrombus completely occluded the carotid artery. Blood was collected by P3 cardiac puncture for whole blood platelet aggregation studies. Elevated BAFF Levels Correlate with Altered B Cell Phenotypes in Results All (n=14) mice treated with anti-hsp60 antibodies developed virtual- Patients with Systemic Lupus Erythematosus ly complete occlusion of the carotid artery, with a mean blood flow of 1.86% Carolina Landolt-Marticorena (Toronto Western Research Institute), Gabriel following thrombus formation: no reperfusion was observed. In contrast, mice Bonventi (Toronto Western Research Institute), Yongchun Cai (Toronto (n=14) treated with control IgG showed greater instability of the thrombus Western Research Institute), Thulasi Unnithan (Toronto Western Research with frequent reperfusion [7/14 mice]) and a mean blood flow of 22.3% fol- Institute), Dafna Gladman (Toronto Western Research Institute), Murray lowing thrombus formation. In vitro collagen-induced platelet aggregation Urowitz (Toronto Western Research Institute), Paul R. Fortin (Toronto using blood from these mice was significantly lower in anti-hsp60-treated than Western Research Institute), Joan E. Wither (Toronto Western Research in control IgG-treated mice (mean resistance: 6.71 versus 10.38 Ohms, p = Institute) 0.017), consistent with prior in vivo activation in the anti-hsp60 mice. Objective It has been demonstrated that lupus patients have elevated serum Conclusion Our findings demonstrate that: i) anti-hsp60 autoantibodies can and RNA levels of BAFF. In transgenic mouse models, BAFF has ubiquitous be induced in nonautoimmune individuals by exposure to a bacterial antigen; effects including rescue of auto-reactive transitional B cells, enhancement of and ii) in a murine model of arterial thrombosis, passively transferred anti- T-B cell collaboration, and expansion of plasma cells. Since these changes hsp60 autoantibodies promote thrombus formation, vascular occlusion, and are similar to those observed in lupus patients, we examined whether BAFF thrombus stabilization. These data provide support for a prothrombotic role of expression correlates with alterations in the peripheral blood B cell compart- anti-hsp60 autoantibodies. Work supported by CIHR and FRSQ “Réseau en ments of lupus patients. santé cardiovasculaire”. Methods Patients (n = 58) satisfying ≥ 4 ACR criteria were recruited from the University of Toronto Lupus Clinic. Healthy controls (n =11) P2 were also recruited. Clinical and demographic information was obtained Human OA Subchondral Bone Remodelling Is Closely Dependent on for all study participants. Disease activity was measured by the RANKL Modulation SLEDAI-2K, with a score of ≥ 7 defined as high disease activity. Steeve Kwan Tat (Osteoarthritis Research Unit, University of Montreal Peripheral blood mononuclear cells from all study participants were iso- Hospital Centre, Notre-Dame Hospital), Jean-Pierre Pelletier (Osteoarthritis lated, stained with various combinations of fluorescently labeled anti- Research Unit, University of Montreal Hospital Centre, Notre-Dame bodies, and analyzed by flow cytometry. RNA was isolated from periph- Hospital), Daniel Lajeunesse (Osteoarthritis Research Unit, University of eral blood and converted to cDNA using a ABI high capacity kit. BAFF Montreal Hospital Centre, Notre-Dame Hospital), Hassan Fahmi RNA expression was measured by qRT-PCR reaction using Taqman Low (Osteoarthritis Research Unit, University of Montreal Hospital Centre, Notre- Density Arrays and normalized to a housekeeping gene (GAPDH). Dame Hospital), Nicolas Duval (Centre de Convalescence Pavillon des Statistical differences between groups where determined by the Mann- Charmilles), Johanne Martel-Pelletier (Osteoarthritis Research Unit, Whitney test. University of Montreal Hospital Centre, Notre-Dame Hospital) Results BAFF RNA expression was significantly elevated in SLE patients as Personal non-commercial use only. The Journal of Rheumatology Copyright © 2008. All rights reserved. CRA - Podium presentations 1171 Downloaded on September 27, 2021 from www.jrheum.org compared to controls (p < 0.0001) and showed an association with high dis- Health Center), Patrick Bélisle (McGill University Health Center), Ann E. ease activity (p = 0.017). As we, and others have shown, lupus patients had Clarke (McGill University Health Center), Christian A. Pineau (McGill significantly elevated levels of pre-germinal center (p < 0.0001) and plasma University Health Center) cells (p = 0.0352) as compared to controls. In the current and previous stud- Objective Over the past three decades, in North America, the proportion of ies, we have noted a trend towards an expansion of the transitional cell com- women training in rheumatology has increased considerably, but there is con- partment in lupus patients when compared to controls. Patients were stratified cern that their academic productivity is inferior to their male counterparts. into high and low levels for each B cell population based on whether the pro- Because publication in medical journals
Recommended publications
  • Ph.D. in Mechanical Engineering with Dissertation in Intelligent Energetic Systems Program
    A proposal for the Doctor of Philosophy Degree in Mechanical Engineering with Dissertation in Intelligent Energetic Systems at the New Mexico Institute of Mining and Technology October 2015 1 Executive Summary ............................................................................................................... 4 A Purpose of the Program ................................................................................................... 5 A.1 The Primary Purpose of the Proposed Program ....................................................... 5 A.2 Consistency of the Proposed Program with the Role and Scope of the Institution .. 6 A.3 Priority of the Institution for the Proposed Program ................................................ 7 A.4 Curriculum ............................................................................................................... 8 B Justification for the Program ......................................................................................... 11 B.1 State and Regional Need ........................................................................................ 11 B.2 Duplication ............................................................................................................. 13 B.3 Inter-Institutional Collaboration and Cooperation ................................................. 16 C Clientele and Projected Enrollment............................................................................... 21 C.1 Clientele ................................................................................................................
    [Show full text]
  • FACTOR Annual Report 2018
    Annual Report 2018—2019 Contents 02 — Message from the Chair 20 — In the Community 03 — Message from the President 21 — Juries 04 — About the Foundation 24 — Programs 06 — Staff 29 — Sponsorship 07 — Board of Directors 32 — Collective Initiatives 08 — National Advisory Board 36 — Success Stories 10 — Our Funding Partners 40 — Awards 12 — Financial Results 44 — Year-End Snapshot 14 — Funding Offered by Genre 48 — PwC Report 16 — Applications by Genre Up+Downtown Music and Arts Festival 2018 — Eric Kozakiewicz FACTOR 2018—2019 1 Message from the Chair Message from the President has been a key focus of the Department of Canadian Heritage and the Canadian presence for our sector at jazzahead! in Bremen. In we continue to support fantastic programs on the global stage support of the Frankfurt Book Fair, we will be assembling events such as Reeperbahn in Germany, Printemps de Bourges in France, to promote Canadian talent at the Berlin Film Festival, Elbjazz, while developing new markets and genre opportunities with and in Hamburg and Munich. As well, we will be creating the Linecheck in Milan, Italy later this year and the Frankfurt Book Fair definitive music show for the Book Fair itself. These events will in Germany in 2020. be done with the support of the Canadian Embassy in Berlin, and the invaluable support of Sound Diplomacy in Germany. Through new CRTC mandates, we have received substantial increased funding for expanded video and other music programs. In the upcoming months we will be working with Manitoba By using new funds from that source and other radio CCD Music, developing and financing opportunities for Indigenous benefits, FACTOR has developed a new program for publishers and artists to showcase in Australia at Big Sound and in Germany expanded the available funding for songwriters’ workshops.
    [Show full text]
  • Place Name Address 1 Samalya Schaefer Berlin 13125 2 Dylan
    Place Name Address 1 Samalya Schaefer Berlin 13125 2 Dylan Carey Millis MA 3 Juan Francisco New York NY 4 Jacob Norris Greene ME 5 Abel Perez Brooklyn NY 6 Owen Ross Closter NJ 7 Jaime Castro New York NY 8 Knox Robinson Brooklyn NY 9 Ricardo Castro New York NY 10 David Malecki Grand Rapids MI 11 Stan Chen Long Island City 12 John LaRosa Danbury CT 13 Simon Taylor New York NY 14 Sean Hamilton Boston MA 15 Apaguha Vesely 12000 Prague 2 16 Ian Smith New York NY 17 Tom Godfrey Brooklyn NY 18 Juan Marcelo Brooklyn NY 19 Jing Jiang Trumbull CT 20 Nigel McGregor New York NY 21 Joshua Gangemi Cambridge MA 22 Adil Filali Bronx NY 23 Michael Minopoli Milford CT 24 Bharu Rother Zurich 25 Alex Syed Tampa FL 26 Albert Wu Brooklyn NY 27 Granantan Boyle Christchurch 28 John Downey Rochester NY 29 Tim Ryan Hopedale MA 30 Matthew Palombaro Glenside PA 31 Matthew Li Briarcliff Manor 32 Ondrej Mocny Prague 33 Brendon McDonough Jersey City NJ 34 Andrea Marcato Oberengstringen 35 Bert Howard Shelton CT 36 Toby Kelleher Brooklyn NY 37 Jorge Pina Lisbon 38 Ananda-Lahari Zuscin Kosice 39 Nenad Moconja Astoria NY 40 David Beauley Chapel Hill NC 41 John Henson Fayetteville GA 42 Joao Theoto Jundiai S.P. 43 Timothy Decker New York NY !1 44 Christiana Prater-Lee Poughkeepsie NY 45 David Joseph Montreal QC 46 Shishaldin Hanlen New York NY 47 Chris Clapp Portsmouth NH 48 Pat Needham Jersey City NJ 49 Darby Dustman Vernon CT 50 Susan Marshall Christchurch 51 Chelsea Beasley Brooklyn NY 52 Marguerite Basta New Canaan CT 53 Shaun Johnson New York NY 54 Tony Cheong Brooklyn
    [Show full text]
  • ECFS-CTN Reporting to Patients 2014
    EUROPEAN CYSTIC FIBROSIS SOCIETY – CLINICAL TRIALS NETWORK ECFS-CTN reporting to patients 2014 European Cystic Fibrosis Society – Clinical Trials Network [email protected] ECFS-CTN reporting to patients 2014 Content GENERAL REPORTING: ............................................................................................................................................ 3 1. WHY ARE CLINICAL TRIALS IMPORTANT? ..................................................................................................................... 3 2. WHAT IS THE ECFS-CTN AND WHICH SITES ARE INVOLVED? ........................................................................................... 3 3. WHAT DOES THE ECFS-CTN DO? ............................................................................................................................. 4 4. WHAT IS THE DIRECT AND POTENTIAL BENEFIT TO PATIENTS? .......................................................................................... 8 5. ECFS-CTN FINANCIAL SUPPORT ............................................................................................................................... 8 6. WHY DOES THE ECFS-CTN NEED YOUR SUPPORT AND WHAT CAN YOU DO TO SUPPORT ECFS-CTN? .................................... 9 2014 ANNUAL REPORTING ................................................................................................................................... 11 1. PARTICIPATING SITES, GOVERNANCE, COMMITTEES ....................................................................................................
    [Show full text]
  • 2019-2020 Directory
    YORK RITE SOVEREIGN COLLEGE OF NORTH AMERICA 500 Temple Avenue,35 Anderson Detroit, Street MI 48201-2693 PhoneMail: (313) PO 833Box- 1385368, Denton,* Fax (313) NC 83327239-7735 Phone Email:(336)859 [email protected] * Fax (336)859 -0454 Email:Website: [email protected] www.yrscna.org Website: www.yrscna.org SOVEREIGN COLLEGE OFFICERS SOVEREIGN 20COLLEGE11-2012 OFFICERS 2019- 2020 JOE R. MANNING, JR., (Cindy), #75 .................................. Governor General PO Box 8, Cushing, OK 74023 * Hm (918) 225-5196 * Fax (918) 225-2611 BLAINE* cell H. (405) SIMONS 820-7509, (Diane * Email:), #190 [email protected] ................................... Governor General 2691 Flamingo Dr., Salt Lake City, UT 84117 GERALD * A.Hm FORD, (801) 272(Audrey),-1787 *#87 Email: ......................... [email protected] Deputy Governor General 11460 West 69th Way, Arvada, CO 80004-2515 * Hm (303) 425-5742 W. BERRY* cell (303) RIGDON 909-8828, (Roseanna * Email:), # [email protected]’s 78/172………Deputy Governor General 124 Rigdon Ln., Waynesville, NC 28786 * Cell (828) 778-1928 DAVID G.* Email:WALKER, [email protected] (Susan), #66 ................................ .... Chancellor General 5130 Elliott Sideroad, Midland, ON L4R 4K3 * Hm (705) 526-2405 J. WILLIAM* Fax (705) RIGGS 526-9431, (Willetta) * Email: # 116 [email protected] ............................... Chancellor General 1044 Eagle Pass, Bardstown, KY .. 40004-9151 *Hm: (502) 348-2469 REESE L.*Cell HARRISON, (502) 432 -JR.5443., (Judith*Email: Karen) [email protected], #’s14/60 ........ Treasurer General 711 Navarro, Suite 600, San Antonio, TX 78205 * Hm (210) 344-7244 REESE* Wk L. HARRISON,(210) 224-2000 JR., * Fax (Judith) (210) #’ 224s 14/60-7540. .................. * cell (210) Treasurer 867-7244 General * Email:2301 [email protected], San Antonio, TX 78215 * Hm (210) 344-7244 * Wk (210) 250-6125 * Fax (210) 258-2733 * Cell (210) 867-7244 D.
    [Show full text]
  • The York Rite Sovereign College of North America Directory 2020-2021
    The York rite Sovereign college Of North America Directory 2020-2021 Kansas City, Missouri July 29 - August 1, 2021 YORK RITE SOVEREIGN COLLEGE OF NORTH AMERICA 500 Temple Avenue,35 Anderson Detroit, Street MI 48201-2693 PhoneMail: (313) PO 833Box- 1385368, Denton,* Fax (313) NC 83327239-7735 Phone (336)Email: 859 [email protected] * Fax (336) 859 -0454 Email:Website: [email protected] www.yrscna.org Website: www.yrscna.org SOVEREIGN COLLEGE OFFICERS SOVEREIGN 20COLLEGE11-2012 OFFICERS 2020- 2022 JOE R. MANNING, JR., (Cindy), #75 .................................. Governor General PO Box 8, Cushing, OK 74023 * Hm (918) 225-5196 * Fax (918) 225-2611 W. BERRY* cell (405) RIGDON 820-7509, (Roseanna * Email:), # [email protected]’s 78/172 .................... Governor General 124 Rigdon Lane, Waynesville, NC, 28786 GERALD * A.Cell FORD, (828) (Audrey),778-1928 *#87 Email: ......................... [email protected] Deputy Governor General 11460 West 69th Way, Arvada, CO 80004-2515 * Hm (303) 425-5742 J. WILLIAM* cell (303) RIGGS, 909-8828 (Willetta * Email:), #116…………...… [email protected] Governor General 1044 Eagle Pass, Bardstown, KY 40004-9151 * Home: (502) 348-2469 DAVID G.*Cell: WALKER, (502) 432 (Susan),-5443 *#66 Email: ................................ [email protected].... Chancellor General 5130 Elliott Sideroad, Midland, ON L4R 4K3 * Hm (705) 526-2405 BRYCE* Fax B. HILDRETH(705) 526-9431, (Natalie) * Email: # [email protected] ........................... ...Chancellor General 4811 NE Delaware Avenue, Ankery, IA 50021 * Cell (515) 360-6167 REESE L.* HARRISON,Email: [email protected] JR.., (Judith Karen) , #’s14/60........ Treasurer General 711 Navarro, Suite 600, San Antonio, TX 78205 * Hm (210) 344-7244 REESE* Wk L. HARRISON,(210) 224-2000 JR., * Fax (Judith) (210) #’ 224s 14/60-7540.
    [Show full text]
  • 1 Long Term Originator Infliximab Treatment Is Predictive of Retention
    1 Long Term Originator Infliximab Treatment is Predictive of Retention in Stable Rheumatic Disease Patients in Canada Philip Baer (Scarborough); Majed Khraishi (Memorial University of Newfoundland, St. John's); Marilise Marrache (Janssen Inc., Toronto); Emmanuel Ewara (Janssen Inc., Toronto) Objectives: To evaluate long-term retention patterns of stable rheumatic disease (RD) patients treated with REMICADE® (infliximab [IFX]). Methods: Using IMS Brogan’s™ database of private and public insurance claims data, our analysis included RD patients with: (1) first IFX claim between Jan 2008-May 2015; (2) no IFX claims 12 months prior to the initial claim; (3) ≥1 claim for any other drug 12 months after the initial IFX claim; and (4) ≥1 claim for any non-IFX drug 4 months after May 2015. Retention was measured at 12-month intervals and unadjusted odds ratios calculated at the 95% confidence interval within and between cohorts of RD patients. Within-group analysis compared 12 month retention by number of years on IFX. Analyses considered cohorts of patients according to age, gender, insurance type, and previous biologic experience. Results: A total of 1,672 had ≥2 years of claims history and had been on IFX for ≥1year. Within-group comparisons showed that a patient’s probability of being retained on IFX in subsequent 12-month periods increased concurrently with elapsed time on IFX. Patients on IFX for 2, 3, 4 and 5 years showed significantly higher retention in the subsequent year compared to patients on IFX for only 1 year (P < 0.05). Similar trends were observed for females, in the 19-64 age range, within naïve and experienced cohorts, and by those patients with private insurance coverage.
    [Show full text]
  • Edition 6 | 2018-2019
    PROMPTER TABLE OF THE BUSHNELL CENTER CONTENTS for the PERFORMING ARTS TRUSTEE OFFICERS Message from the President & CEO ..................... 5 Jay S. Benet Chair Charlie and the Chocolate Factory Feburary 19-24 Robert E. Patricelli Co-Sponsored by Immediate Past Chair People’s United Bank and Travelers .................. 13 Thomas O. Barnes Vice Chair Annual Fund Donor Honor Roll ......................... 25 Jeffrey N. Brown Vice Chair An Extra Special Thank You ............................... 30 Jeffrey S. Hoffman Vice Chair The Bushnell Services ....................................... 35 David G. Nord Vice Chair David M. Roth Vice Chair Henry M. Zachs Vice Chair Arnold C. Greenberg Treasurer Mark N. Mandell Assistant Treasurer Eric D. Daniels Secretary EXECUTIVE STAFF David R. Fay President and CEO Ronna L. Reynolds Executive Vice President Elizabeth Casasnovas Vice President, Development, and Chief Development Officer Patti Jackson Vice President, Finance, and Chief Financial Officer Yolande Spears Senior Vice President, Education and Community Initiatives Ric Waldman Vice President, Programming and Marketing The Bushnell is a 501(c)(3) not-for-profit organization that is proud to serve Connecticut and its citizens. | 3 MESSAGE FROM THE PRESIDENT & CEO Sweet Treats Welcome to The And while you’re looking at our videos, Bushnell and this I invite you to check out our Mission Moments much-anticipated playlist (www.youtube.com/TheBushnell166/ production of Charlie playlists), an ongoing series of special video and the Chocolate productions that highlight our community Factory. Roald Dahl has outreach and education initiatives. These had quite a Broadway run in compelling pieces illustrate how your generous recent years (we presented the tour of Matilida donations to The Bushnell impact the lives of in 2016), and it’s the appeal of his stories to a students and their communities throughout wide range of audience members that makes the state.
    [Show full text]